Dr. Joyce Ann O'Shaughnessy MD Medical Oncologist

Dr. Joyce O'Shaughnessy is a medical oncologist in Dallas, Texas. She is affiliated with multiple hospitals in the area, including Baylor University Medical Center and Medical City Dallas Hospital. She received her medical degree from Yale University School of Medicine and has been in practice for 32 years. She is one of 29 doctors at Baylor University Medical Center and one of 35 at Medical City Dallas Hospital who specialize in Medical Oncology.

Are you Dr. Joyce O'Shaughnessy? Claim your profile to make edits or add details. Claim/Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Medical Oncologist: General Oncology

Hospital Affiliation

Baylor University Medical Center
High performing in Cancer

Medical City Dallas Hospital
High performing in Cancer

Education & Medical Training

Massachusetts General Hospital
Residency, Internal Medicine, 1982 - 1985

National Cancer Institute
Fellowship, Medical Oncology, 1985 - 1988

Yale University School of Medicine
Class of 1982

Certifications & Licensure

American Board of Family Medicine
Certified in Family Medicine

American Board of Family Medicine
Certified in Sports Medicine

AZ State Medical License
Active through 2014

Awards, Honors & Recognition

Meaningful Use Stage 1 Certification, Centers for Medicare & Medicaid Services
2011

Publications & Presentations

Treatment effect of capecitabine and docetaxel or docetaxel alone by oestrogen receptor status in patients with metastatic breast cancer: Results of an exploratory analysis.
Glück, S.,Russell, C.,O'Shaughnessy, J.,McKenna, E. F.,Hu, S.,Odom, D.,Blum, J. L.

Phase II randomized trial of weekly and every-3-week ixabepilone in metastatic breast cancer patients.
Smith, J. W.,Vukelja, S.,Rabe, A.,Wentworth-Hartung, N.,Koutrelakos, N.,Shao, S. H.,Whittaker, T.,Wang, Y.,Asmar, L.,McDowell, D. O.,Mukhopadhyay, P.,O'Shaughnessy, J.

Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study.
Jones, S. E.,Collea, R.,Paul, D.,Sedlacek, S.,Favret, A. M.,Gore, I.,Lindquist, D. L.,Holmes, F. A.,Allison, M. A.,Brooks, B. D.,Portillo, R. M.,Vukelja, S. J.,Steinberg, M. S.,Stokoe, C.,Crockett, M. W.,Wang, Y.,Asmar, L.,Robert, N. J.,O'Shaughnessy, J.

See all 47 publications

Insurances Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • BCBS Blue Card PPO
  • BCBS Texas BlueChoice
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • Empire BCBS HMO
  • Empire BCBS PPO
  • First Health PPO
  • GHI PPO
  • Great West PPO
  • HIP of New York - Select PPO
  • Humana ChoiceCare Network PPO
  • MagnaCare PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • MVP Healthcare PPO
  • Oxford Health Freedom
  • Oxford Health Liberty
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by

Specialty

Location

Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.